Targeting heterogeneity in human Glioblastoma with mRNA-based Multispecific CAR-T Cells.

Research unit

INNOSUISSE

Project number

120.190 IP-LS

Project title

Targeting heterogeneity in human Glioblastoma with mRNA-based Multispecific CAR-T Cells.

Texts for this project

	German	French	Italian	English
Key words	-	-	-
Abstract	-	-	-

Category	Text
Key words (English)	Life sciences, Human medicine
Abstract (English)	Cellula Therapeutics is dedicated to developing a multispecific, transient expression vector-based autologous CAR-T cell therapy for glioblastoma multiforme (GBM), a form of brain cancer with a median survival rate of less than 2 years after diagnosis.